Brief: Novocure Announces Last Patient Enrolled In Phase 3 Trident Trial In Newly Diagnosed Glioblastoma
09/01/2024 13:32
Jan 9 (Reuters) - Novocure Ltd NVCR.O :
* NOVOCURE ANNOUNCES LAST PATIENT ENROLLED IN PHASE 3
TRIDENT
TRIAL IN NEWLY DIAGNOSED GLIOBLASTOMA
* NOVOCURE LTD: FINAL DATA FROM TRIDENT TRIAL ANTICIPATED IN
2026
Source text for Eikon: ID:nBwmjXrGa
Further company coverage: NVCR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NovoCure
See all newsOncology firm Novocure says cyberattack exposed US patient records
Novocure Ltd reports results for the quarter ended June 30 - Earnings Summary
Novocure Q2 revenue beats, lifts 2026 outlook
Brief: Novocure Q2 Revenue USD 183.584 Million Vs. IBES Estimate USD 172.4 Million
U.S. STOCKS ON THE MOVE-Kardigan, Energy companies, Take-Two, Accenture